The Patent Finder

Elitechgroup MDX LLC

26 patents currently held · Updated Nov 14, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 21, 2027
    The maintenance fee for Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use (US 9,085,800) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
  • 1 fee due Apr 27, 2027
    The maintenance fee for Artificial nucleic acids (US 9,169,256) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
  • 2 fees due Sep 5 to 17, 2027 · next Sep 5
  • 2 fees due Nov 3 to 10, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,671,218Phosphonate fluorescent dyes and conjugates
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,767,834Phosphonylated fluorescent dyes and conjugates
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,163,910Amide-substituted xanthene dyes
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,980,855Minor Groove Binder (MGB)-Oligonucleotide Mirna Antagonists
In force
 · Medium confidence
In forceMedium confidence
US 9,334,495Minor groove binder (MGB)-oligonucleotide miRNA antagonists
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,127,349Method of producing oligomer affinity pairs
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,969,003Functionalized 3-Alkynyl Pyrazolopyrimidine Analogues as Universal Bases and Methods of Use
In force
 · Medium confidence
In forceMedium confidence
US 9,085,800Functionalized 3-alkynyl pyrazolopyrimidine analogues as universal bases and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,932,643Detection of methicillin-resistant Staphylococcus aureus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,056,887Minor Groove Binder Phosphoramidites and Methods of Use
In force
 · High confidence
In forceHigh confidence
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
Also on record, not counted in the 26: 18 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited